The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Exane Raises M&S; HSBC Ups Diploma To Buy

Fri, 12th Feb 2021 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

----------

FTSE 100

----------

RBC REINITIATES LONDON STOCK EXCHANGE WITH 'OUTPERFORM' - PRICE TARGET 11,500 PENCE

----------

KEPLER CHEUVREUX RAISES RELX PRICE TARGET TO 2,075 (1,960) PENCE - 'BUY'

----------

BARCLAYS RAISES RELX PRICE TARGET TO 2,090 (2,070) PENCE - 'OVERWEIGHT'

----------

BERENBERG RAISES COMPASS GROUP PRICE TARGET TO 1,600 (1,425) PENCE - 'BUY'

----------

BERENBERG RAISES WHITBREAD PRICE TARGET TO 3,600 (2,500) PENCE - 'BUY'

----------

BERENBERG RAISES INTERCONTINENTAL HOTELS TARGET TO 4,500 (4,000) PENCE - 'HOLD'

----------

MORGAN STANLEY CUTS GLAXOSMITHKLINE PRICE TARGET TO 1,580 (1,665) PENCE - 'EQUAL-WEIGHT'

----------

MORGAN STANLEY INITIATES FERGUSON WITH 'EQUAL-WEIGHT' - TARGET 9,060 PENCE

----------

DEUTSCHE BANK RAISES COCA-COLA HBC PRICE TARGET TO 2,900 (2,800) PENCE - 'BUY'

----------

GOLDMAN RAISES COCA-COLA HBC PRICE TARGET TO 2,700 (2,670) PENCE - 'BUY'

----------

JEFFERIES RAISES COCA-COLA HBC PRICE TARGET TO 2,800 (2,750) PENCE - 'BUY'

----------

FTSE 250

----------

EXANE RAISES MARKS & SPENCER TO 'OUTPERFORM' ('NEUTRAL') - PRICE TARGET 165 (140) PENCE

----------

BERENBERG RAISES SSP GROUP PRICE TARGET TO 370 (335) PENCE - 'BUY'

----------

BERENBERG CUTS TUI PRICE TARGET TO 175 (250) PENCE - 'SELL'

----------

BERENBERG CUTS CARNIVAL TO 'SELL' ('HOLD') - TARGET 1,000 (800) PENCE

----------

CREDIT SUISSE RAISES WIZZ AIR PRICE TARGET TO 5,788 (4,889) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES EASYJET PRICE TARGET TO 1,032 (842) PENCE - 'OUTPERFORM'

----------

LIBERUM RAISES ROYAL MAIL PRICE TARGET TO 480 (320) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES ROYAL MAIL PRICE TARGET TO 680 (550) PENCE - 'BUY'

----------

BERNSTEIN RAISES ROYAL MAIL PRICE TARGET TO 400 (310) PENCE - 'MARKET-PERFORM'

----------

JPMORGAN RAISES ROYAL MAIL PRICE TARGET TO 641 (568) PENCE - 'OVERWEIGHT'

----------

UBS RAISES REDROW PRICE TARGET TO 885 (750) PENCE - 'BUY'

----------

JEFFERIES RAISES CRANSWICK PRICE TARGET TO 3,700 (3,600) PENCE - 'HOLD'

----------

JPMORGAN CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 830 (900) PENCE - 'OVERWEIGHT'

----------

MORGAN STANLEY RAISES DRAX GROUP TARGET TO 400 (300) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN RAISES VICTREX PRICE TARGET TO 2,150 (2,000) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK RAISES POLYPIPE PRICE TARGET TO 653 (602) PENCE - 'BUY'

----------

HSBC RAISES DIPLOMA TO 'BUY' ('HOLD') - TARGET 2,705 (1,680) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

MORGAN STANLEY INITIATES BREEDON WITH 'OVERWEIGHT' - TARGET 114 PENCE

----------

PEEL HUNT RAISES HELICAL TO 'BUY' ('ADD') - TARGET 425 (450) PENCE

----------

CREDIT SUISSE RAISES RYANAIR PRICE TARGET TO 17.91 (17.23) EUR - 'OUTPERFORM'

----------

GOLDMAN CUTS TED BAKER PRICE TARGET TO 100 (130) PENCE - 'NEUTRAL'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.